CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. (CERO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cero · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Hold
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.01
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↓ 5.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CERO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-18 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2025-10-30 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-10-22 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-10-13 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-23 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-09 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-05 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-04 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-06-24 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-06-23 | D. Boral Capital | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on CERo Therapeutics Holdings, Inc. (CERO) stock. Of the recent 13 rating actions, 1 were upgrades and 2 were downgrades. 1 analysts currently cover CERO.
Analyst Recommendation Trends
CERO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-2.50
EPS Next Year
$-3.26
↑ 30.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CERO EPS of $-2.50 for the current fiscal year, based on estimates from 1 analysts. The CERO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CERO stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CERO price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The CERO short-term stock prediction for tomorrow is $0.01 (-5.00%).
CERo Therapeutics Holdings, Inc. trades on OTC under the ticker CERO. The CERO stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
CERO forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month CERO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.